Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party

McLornan, DP; Boluda, JCH; Czerw, T; Cross, N; Deeg, HJ; Ditschkowski, M; Moonim, MT; Polverelli, N; Robin, M; Aljurf, M; Conneally, E; Hayden, P; Yakoub-Agha, I

McLornan, DP (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Haematol, London, England.; McLornan, DP (corresponding author), Univ Coll Hosp, London, England.; Yakoub-Agha, I (corresponding author), Univ Lille, CHU Lille, INSERM, Infinite,U1286, Lille, France.

LEUKEMIA, 2021; 35 (9): 2445

Abstract

Allogeneic haematopoietic cell transplantation (allo-HCT) remains the only curative approach in myelofibrosis (MF). Despite advances over recent decad......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索